Blindness News and Research

RSS
Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Can-Fite BioPharma to commence Glaucoma Phase II clinical study in Israel

Can-Fite BioPharma to commence Glaucoma Phase II clinical study in Israel

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Alcon signs definitive agreement to acquire Optonol

Alcon signs definitive agreement to acquire Optonol

By understanding how gene works, scientists may find ways to prevent, cure diabetes

By understanding how gene works, scientists may find ways to prevent, cure diabetes

Stem cell therapy can be used for LSCD, reports newly published research

Stem cell therapy can be used for LSCD, reports newly published research

Novartis presents 6-month results from its EVEREST study for PCV

Novartis presents 6-month results from its EVEREST study for PCV

VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

TECHGENE project: CLC bio selected as software partner

TECHGENE project: CLC bio selected as software partner

New findings may help restore vision in patients with corneal injury

New findings may help restore vision in patients with corneal injury

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

CAM314 randomized Phase 3 clinical trial results released

CAM314 randomized Phase 3 clinical trial results released

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

Humans and mice have critical differences in gene responsible for DMD

Humans and mice have critical differences in gene responsible for DMD

Research study shows usage of stem cell-based therapies for treating age-related macular degeneration

Research study shows usage of stem cell-based therapies for treating age-related macular degeneration

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

Macular Health eye vitamin supplement improves visual acuity

Macular Health eye vitamin supplement improves visual acuity

Pycnogenol can improve microcirculation, retinal edema and visual acuity, reveals study

Pycnogenol can improve microcirculation, retinal edema and visual acuity, reveals study

New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathy

New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathy

Roche announces results of phase III taspoglutide study in diabetes patients

Roche announces results of phase III taspoglutide study in diabetes patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.